Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.

R. Hoekstra; FYFL de Vos; F.A. Eskens; J.A. Gietema; Ate van der Gaast; Harry J M Groen; RA Knight; R.A. Carr; R.A. Humerickhouse; J Verweij; E.G.E. de Vries

Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.

R. Hoekstra, FYFL de Vos, F.A. Eskens, J.A. Gietema, Ate van der Gaast, Harry J M Groen, RA Knight, R.A. Carr, R.A. Humerickhouse, J Verweij, E.G.E. de Vries

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	5188-5197
Journal	Journal of Clinical Oncology
Volume	23
Issue number	22
Publication status	Published - Aug 2005

Cite this

Hoekstra, R., de Vos, FYFL., Eskens, F. A., Gietema, J. A., van der Gaast, A., Groen, H. J. M., Knight, RA., Carr, R. A., Humerickhouse, R. A., Verweij, J., & de Vries, E. G. E. (2005). Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. Journal of Clinical Oncology, 23(22), 5188-5197.

@article{f189dea90821456282ed2ded678bfbb6,

title = "Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.",

author = "R. Hoekstra and {de Vos}, FYFL and F.A. Eskens and J.A. Gietema and {van der Gaast}, Ate and Groen, {Harry J M} and RA Knight and R.A. Carr and R.A. Humerickhouse and J Verweij and {de Vries}, E.G.E.",

year = "2005",

month = aug,

language = "English",

volume = "23",

pages = "5188--5197",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "22",

}

Hoekstra, R, de Vos, FYFL, Eskens, FA, Gietema, JA, van der Gaast, A, Groen, HJM, Knight, RA, Carr, RA, Humerickhouse, RA, Verweij, J & de Vries, EGE 2005, 'Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.', Journal of Clinical Oncology, vol. 23, no. 22, pp. 5188-5197.

TY - JOUR

T1 - Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.

AU - Hoekstra, R.

AU - de Vos, FYFL

AU - Eskens, F.A.

AU - Gietema, J.A.

AU - van der Gaast, Ate

AU - Groen, Harry J M

AU - Knight, RA

AU - Carr, R.A.

AU - Humerickhouse, R.A.

AU - Verweij, J

AU - de Vries, E.G.E.

PY - 2005/8

Y1 - 2005/8

M3 - Article

SN - 0732-183X

VL - 23

SP - 5188

EP - 5197

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 22

ER -